StarkAge Therapeutics
Biotechnology Research
Lille, Nord, Fr
11 employees
- Employees
- 11
- Contacts
- 2
- Emails
- 2
- Phones
- 1
StarkAge Therapeutics Overview
- Headquarters
- Lille, Nord, Fr
- Website
- starklabs.eu
- Industry
- Biotechnology Research
- Employees
- 11
- Founded
- 2018
- Funding
- 1.3M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About StarkAge Therapeutics
StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs.
StarkAge Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
StarkAge Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Florence Lhospice | Adc Development Consultant_board | France |
Email
|
| Cedric Mathieu | Chief Business Officer at Turo | Toronto, Ontario, Canada |
Email
Phone
|
| Thierry Mathieu | Founder and President, Starkage |
View
|
|
| Jennifer Campbell | Global Corporate Communications |
View
|
Employees by Management Level
Executive
2 profiles
Individual contributor
2 profiles
Compare Similar Companies to StarkAge Therapeutics
Innate Pharma
Biotechnology Research
GenoScreen
Biotechnology Research
4P-Pharma
Biotechnology Research
Pan Cancer T
Biotechnology Research
Seekyo Therapeutics
Biotechnology Research
Persea
Biotechnology Research
APTEEUS
Biotechnology Research
HyprView
Technology, Information And Internet
See2cure
Biotechnology Research
CARLA Biotherapeutics
Biotechnology Research